Benzinga
Benzinga
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Benzinga
vendredi, novembre 13
Actualités France
Bourse
Economie
Général
Actualités Américaines
Bourse
Bénéfices
Economie
Marchés prédictifs
Marchés privés
Autres marchés
Recommandations des analystes
Trading
Communiqués de presse
Mondial
Asie
Crypto-monnaies
Actualités cryptos
Altcoins
Bitcoin
Dogecoin
Ethereum
Shiba Inu
NFT
Éducation
Investir en crypto
Investir en bourse
Forex
Haemonetics Corp
HAE
NYSE
Liste de surveillance
Get Report
Trade with Public
Get Report
Trade with Public
$122.96
0.25
0.2%
À la clôture: Nov 13, 4:00 PM EST
Get Report
Aperçu
Actualités
Graphiques
Prévisions de résultats
Événements
Objectifs de cours
Données financières
Sentiment
Actionnariat
Comparer
Rapport sur les stocks
Haemonetics Financials
Haemonetics (HAE) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Haemonetics Raises FY2027 Sales Guidance from $1.401B-$1.441B to $1.441B-$1.481B vs $1.418B Est
Haemonetics (NYSE:HAE) raises FY2027 sales outlook from $1.401 billion-$1.441 billion to $1.441 billion-$1.481 billion vs $1.418 billion estimate.
Benzinga Newsdesk
PRO
Haemonetics Q2 Adj. EPS $1.35 Beats $1.29 Estimate, Sales $357.759M Beat $345.003M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.35 per share which beat the analyst consensus estimate of $1.29 by 4.65 percent. This is a 6.3 percent increase over earnings of $1.27 per share from the same
Benzinga Newsdesk
PRO
Haemonetics Q1 Adj. EPS $1.14 Beats $1.08 Estimate, Sales $339.380M Beat $327.894M Estimate
Benzinga Newsdesk
PRO
Haemonetics Widens FY2027 Sales Guidance from $1.410B-$1.427B to $1.401B-$1.441B vs $1.402B Est
Haemonetics (NYSE:HAE) widens FY2027 sales outlook from $1.410 billion-$1.427 billion to $1.401 billion-$1.441 billion vs $1.402 billion estimate.
Benzinga Newsdesk
PRO
Haemonetics Sees FY2027 Adj EPS $5.26-$5.31 vs $5.29 Est; Sees Sales $1.410B-$1.427B vs $1.394B Est
FISCAL 2027 GUIDANCEThe Company issued its fiscal 2027 GAAP total revenueand organic revenue growth guidance as follows: Total CompanyReported Revenue4 - 7%53rd week
Benzinga Newsdesk
PRO
Haemonetics Q4 Adj. EPS $1.29 Beats $1.27 Estimate, Sales $346.351M Beat $336.862M Estimate
Haemonetics (NYSE:HAE) reported quarterly earnings of $1.29 per share which beat the analyst consensus estimate of $1.27 by 1.57 percent. This is a 4.03 percent increase over earnings of $1.24 per share from the same
Benzinga Newsdesk
